Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Linear Formula:
Br2CHCHBr2
CAS Number:
Molecular Weight:
345.65
PubChem Substance ID:
UNSPSC Code:
12352101
Beilstein/REAXYS Number:
1098321
MDL number:
Assay:
≥98.0%
Grade:
SAJ first grade
Bp:
119 °C/15 mmHg (lit.)
Vapor pressure:
0.1 mmHg ( 20 °C)
grade
SAJ first grade
vapor density
11.9 (vs air)
vapor pressure
0.1 mmHg ( 20 °C)
assay
≥98.0%
form
liquid
autoignition temp.
635 °F
availability
available only in Japan
dilution
(for analytical testing)
refractive index
n20/D 1.637 (lit.)
bp
119 °C/15 mmHg (lit.)
mp
−1-1 °C (lit.)
density
2.967 g/mL at 25 °C (lit.)
SMILES string
BrC(Br)C(Br)Br
InChI
1S/C2H2Br4/c3-1(4)2(5)6/h1-2H
InChI key
QXSZNDIIPUOQMB-UHFFFAOYSA-N
Still not finding the right product?
Explore all of our products under 1,1,2,2-Tetrabromoethane
signalword
Danger
hcodes
Hazard Classifications
Acute Tox. 2 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Eye Irrit. 2 - Skin Irrit. 2
Storage Class
6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Zhaojiang Guo et al.
Journal of invertebrate pathology, 126, 21-30 (2015-01-18)
The Gram-positive bacterium Bacillus thuringiensis (Bt) produces Cry toxins that have been used to control important agricultural pests. Evolution of resistance in target pests threatens the effectiveness of these toxins when used either in sprayed biopesticides or in Bt transgenic
R Galuppi et al.
Veterinary parasitology, 210(1-2), 10-18 (2015-04-15)
The present study aims to evaluate the prevalence, pattern of spread and risk factors for the transmission of cryptosporidiosis in foals and mares hospitalized in a University Equine Perinatology Unit, where a new subtype family of Cryptosporidium horse genotype was
Stefania Napolitano et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, 21(13), 2975-2983 (2015-04-04)
In colorectal cancer, the activation of the intracellular RAS-RAF and PIK3CA-AKT pathways has been implicated in the resistance to anti-EGFR mAbs. We have investigated the role of regorafenib, an oral multikinase inhibitor, in combination with cetuximab, an anti-EGFR mAb, to
